ABU DHABI: The National Multiple Sclerosis Society (NMSS), a UAE-based NGO established under the Ministry of Community Development that leverages education, advocacy, and global cure-seeking efforts to improve the lives of people living with Multiple Sclerosis (MS), has signed a Memorandum of Understanding (MoU) with the Authority of Social Contribution – Ma’an to establish NMSS’s first official fundraising campaign.
The partnership was signed in the presence of Dr. Fatima Al Kaabi, Vice-Chair of the NMSS, Director General of Emirates Drug Establishment and Executive Director of Abu Dhabi Bone Marrow Transplant programme at Abu Dhabi Stem Cells Center (ADSCC), and Salama Al Ameemi, Director General of the Authority of Social Contribution – Ma’an.
The fundraising campaign will unite the two entities’ resources and efforts in a bid to generate contributions from individuals and companies via the Ma’an Social Contribution Platform – the official channel to receive contributions aimed at supporting social prior
ities in Abu Dhabi. 100 percent of the proceeds from the initiative will be used to improve the lives of people with multiple sclerosis living in the UAE through the provision of support, raising awareness, and advancing research efforts – all while working towards finding a cure for MS.
This partnership aligns with Ma’an’s mission of developing collaborative cohesive communities by enabling a strong and active Third Sector to address social priorities in Abu Dhabi. The fund will also help deliver support programmes, improve healthcare services, and provide a community for people in the Emirates affected by MS.
Commenting on the MoU agreement, Dr. Fatima Al Kaabi, Vice Chair of the NMSS, Director General of Emirates Drug Establishment and Executive Director of Abu Dhabi Bone Marrow Transplant programme at Abu Dhabi Stem Cells Centre (ADSCC), said, ‘We’re delighted to be announcing the launch of our first official donation fund in partnership with Ma’an. Working in unison with a shared objective, utilising c
ontributions from organisations and individuals to help improve the lives of people living with MS in the UAE, supporting programmes and awareness campaigns to enhance wellbeing. All contributions received will assist people living with MS in a number of ways, and also fund today’s treatment and tomorrow’s research to achieve a future free of MS, in line with our society’s goals and vision.’
Salama Al Ameemi, Director General of the Authority of Social Contribution – Ma’an, added, ‘Ma’an recognises the significance of partnerships in achieving sustainable social impact. The emphasis on both supporting programmes for individuals with multiple sclerosis (MS) and raising awareness about the condition within the Abu Dhabi community reflects a holistic approach to addressing social priorities.
By fostering programmes to support social initiatives aligned with the key priorities of Abu Dhabi residents, Ma’an enables the growth of a thriving Third Sector to drive social innovation and contribute to the overall wel
l-being of the community to create a positive and lasting impact.
Source: Emirates News Agency